Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

IQVIA Holdings Inc. (IQV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
248.85+2.03 (+0.82%)
At close: 4:04PM EDT
248.85 +0.03 (+0.01%)
After hours: 04:17PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close246.82
Open248.31
Bid248.71 x 1100
Ask248.85 x 1200
Day's Range246.57 - 250.31
52 Week Range150.66 - 265.34
Volume553,963
Avg. Volume697,832
Market Cap47.683B
Beta (5Y Monthly)1.43
PE Ratio (TTM)79.76
EPS (TTM)3.12
Earnings DateOct 21, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est281.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for IQV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IQVIA Holdings, Inc.
    Analyst Report: IQVIA Holdings Inc.IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
    Rating
    Fair Value
    Economic Moat
    20 days agoMorningstar
View more
  • Zacks

    IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 Release

    IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    IQVIA to Announce Third-Quarter 2021 Results on October 21, 2021

    RESEARCH TRIANGLE PARK, N.C., October 12, 2021--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2021 financial results before the market opens on Thursday, October 21, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

  • Business Wire

    IQVIA to Host Financial Analyst and Investor Conference on November 16, 2021

    RESEARCH TRIANGLE PARK, N.C., October 07, 2021--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, November 16, 2021. Management will provide an update on the business, with presentations starting at 10:00 a.m. ET and concluding at approximately 12:30 p.m. ET. Registration is required to attend the event.

Advertisement
Advertisement